Skip to main content
. 2016 Sep 6;109(1):djw177. doi: 10.1093/jnci/djw177

Table 3.

Bilateral oophorectomy and risk of breast cancer in BRCA1 and BRCA2 mutation carriers

Variable Age-adjusted HR (95% CI) P Multivariable* HR (95% CI) P
Oophorectomy†
No 1.00 (Referent) 1.00 (Referent)
Yes 0.91 (0.71 to 1.16) .43 0.89 (0.69 to 1.14) .35
Family history of breast cancer‡
0 family members 1.00 (Referent) 1.00 (Referent)
1 family member 1.38 (1.06 to 1.76) .01 1.36 (1.06 to 1.75) .02
≥2 family members 1.34 (0.93 to 1.94) .12 1.38 (0.95 to 2.00) .09
Oral contraceptive use
Never 1.00 (Referent) 1.00 (Referent)
Ever 1.08 (0.87 to 1.35) .48 1.38 (0.95 to 2.00) .16
BRCA mutation
BRCA1§ 1.00 (Referent) 1.00 (Referent)
BRCA2§ 0.81 (0.62 to 1.08) .15 0.86 (0.62 to 1.20) .38
Country of residence
Poland 1.00 (Referent) 1.00 (Referent)
Canada 0.78 (0.59 to 1.03) .08 0.77 (0.54 to 1.08) .13
Other 1.00 (0.73 to 1.36) .98 0.80 (0.48 to 1.34) .41
United States 0.99 (0.74 to 1.34) .96 0.97 (0.69 to 1.38) .88
*

Adjusted for the other variables in the model and also for age at menarche (≤12, 13, ≥14 years), parity (0, 1, 2, 3, ≥4 children), and breastfeeding (ever/never). CI = confidence interval; HR = hazard ratio.

†Oophorectomy was coded as a time-dependent covariate. Oophorectomy refers to bilateral oophorectomies only. Others variables were dichotomized based on exposure at baseline.

‡Number of affected first-degree relatives.

§Women with both a BRCA1 and BRCA2 mutation were coded as missing.